Giant Fold Gastritis Induced by Epoprostenol Infusion in Patients With Pulmonary Arterial Hypertension

被引：3
|
作者：
Miura, Yohei [1 ]
Kataoka, Masaharu [3 ]
Chiba, Tomohiro [2 ]
Inami, Takumi [1 ]
Yoshino, Hideaki [1 ]
Satoh, Toru [1 ]
机构：
[1] Kyorin Univ, Sch Med, Dept Internal Med 2, Div Cardiol, Tokyo, Japan
[2] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan
[3] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan
来源：
CIRCULATION JOURNAL | 2018年 / 82卷 / 10期
关键词：
Epoprostenol; Giant fold gastritis; Pulmonary arterial hypertension; Stomach barium examination; THERAPY;
D O I：
10.1253/circj.CJ-18-0349
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Background: Epoprostenol infusion is the strongest and most convincing therapeutic strategy for severe pulmonary arterial hypertension (PAH). This study investigated the gastrointestinal side effects of epoprostenol. Methods and Results: The study group of 12 patients treated with epoprostenol (epoprostenol group) and 4 patients without epoprostenol (control group) underwent stomach barium examination, which revealed that the prevalence of giant fold gastritis was significantly higher in the patients treated with epoprostenol (75% in epoprostenol group vs. 0% in control group; P=0.019). Conclusions: Giant fold gastritis may be an important side effect of epoprostenol infusion.
引用
收藏
页码：2676 / 2677
页数：2
相关论文
共 50 条
  • [31] Transitioning from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension
    Vachiéry, JL
    Hill, N
    Zwicke, D
    Barst, R
    Blackburn, S
    Naeije, R
    CHEST, 2002, 121 (05) : 1561 - 1565
  • [32] Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
    Yuichi Tamura
    Tomohiko Ono
    Keiichi Fukuda
    Toru Satoh
    Shigetake Sasayama
    Advances in Therapy, 2013, 30 : 459 - 471
  • [33] Withdrawal of long-term epoprostenol therapy in pulmonary arterial hypertension (PAH)
    Calcaianu, George
    Calcaianu, Mihaela
    Canuet, Matthieu
    Enache, Irina
    Kessler, Romain
    PULMONARY CIRCULATION, 2017, 7 (02) : 439 - 447
  • [34] Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension
    Lambert, Olivier
    Bandilla, Dirk
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 235 - 244
  • [35] Intravenous Epoprostenol for Management of Pulmonary Arterial Hypertension during Pregnancy
    Timofeev, Julia
    Ruiz, George
    Fries, Melissa
    Driggers, Rita W.
    AJP REPORTS, 2013, 3 (02): : 71 - 74
  • [36] Rapid switch from intravenous epoprostenol to intravenous treprostinil in patients with pulmonary arterial hypertension
    Sitbon, Olivier
    Manes, Alessandra
    Jais, Xavier
    Pallazini, Massimiliano
    Humbert, Marc
    Presotto, Luis
    de Nillette, Louis
    Zaccardelli, Divid
    Davis, Gillian
    Jeff, Roger
    Simonneau, Gerald
    Galie, Naareno
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 49 (01) : 1 - 5
  • [37] Current epoprostenol use in patients with severe idiopathic, heritable or anorexigen-associated pulmonary arterial hypertension: Data from the French pulmonary hypertension registry
    Bergot, Emmanuel
    Sitbon, Olivier
    Cottin, Vincent
    Prevot, Gregoire
    Canuet, Matthieu
    Bourdin, Arnaud
    de Groote, Pascal
    Rottat, Laurence
    Gressin, Virginie
    Jais, Xavier
    Humbert, Marc
    Simonneau, Gerald
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (03) : 561 - 567
  • [38] Primary pulmonary hypertension treated with short-term epoprostenol infusion
    Shiota, Y
    Mikawa, Y
    Arikita, H
    Nakashima, T
    Horita, N
    Hiyama, J
    Ono, T
    Yamakido, M
    INTERNAL MEDICINE, 2003, 42 (09) : 824 - 826
  • [39] Efficacy of acute inhalation of nitric oxide in patients with primary pulmonary hypertension using chronic use of continuous epoprostenol infusion
    Saji, K
    Sakuma, M
    Suzuki, J
    Takahashi, T
    Demachi, J
    Nawata, J
    Kitamukai, O
    Onoue, N
    Sugimura, K
    Tada, T
    Fukui, S
    Kagaya, Y
    Watanabe, J
    Shirato, K
    CIRCULATION JOURNAL, 2005, 69 (03) : 335 - 338
  • [40] Pulmonary edema during acute infusion of epoprostenol in a patient with pulmonary hypertension and limited scleroderma
    Farber, HW
    Graven, KK
    Kokolski, G
    Korn, JH
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (05) : 1195 - 1196
12345